US Stock MarketDetailed Quotes

CYDY CYTODYN INC

Watchlist
  • 0.115000
  • -0.003100-2.62%
15min DelayClose Nov 22 16:00 ET
140.28MMarket Cap-5750P/E (TTM)

About CYTODYN INC Company

CytoDyn, Inc. is a clinical-stage biotechnology company, which focuses on the clinical development of innovative treatments for multiple therapeutic indications based on its product candidate, leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5. Its pipeline includes Leronlimab Clinical Development Pipeline and Long-Acting CCR5 Inhibitor Development Pipeline. The company was founded by Allen D. Allen on May 2, 2002 and is headquartered in Vancouver, WA.

Company Profile

SymbolCYDY
Company NameCYTODYN INC
Founded2002
MarketPink Market
Employees9
Fiscal Year Ends05-31
Address1111 Main Street,Suite 660
CityVancouver
ProvinceWashington
CountryUnited States of America
Zip Code98660
Phone1-360-980-8524
Websitehttp://www.cytodyn.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jacob Lalezari
  • Chief Executive Officer
  • --
  • Mitch Cohen
  • Interim Chief FInancial Officer
  • --
  • Tyler Blok
  • Chief Legal Officer
  • --
  • Bernie Cunningham
  • Vice President, Operations
  • --
  • Joseph Meidling
  • Vice President, Clinical Operations
  • --
  • Cyrus Arman
  • Senior Vice President, Business Operations
  • --
  • Tanya Durkee Urbach
  • Chairman of the Board
  • --
  • Lishomwa C. Ndhlovu
  • Director
  • --
  • Karen J. Brunke
  • Director
  • --
  • Ryan Dunlap
  • Director
  • --
  • Stephen M. Simes
  • Director
  • --
  • Scott Hansen
  • Head of Research and Basic Science
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data